Biscetti, Federico
 Distribuzione geografica
Continente #
NA - Nord America 4.750
EU - Europa 3.466
AS - Asia 3.165
SA - Sud America 570
AF - Africa 86
OC - Oceania 24
Continente sconosciuto - Info sul continente non disponibili 6
Totale 12.067
Nazione #
US - Stati Uniti d'America 4.628
SG - Singapore 1.455
CN - Cina 692
PL - Polonia 620
DE - Germania 617
IT - Italia 534
SE - Svezia 499
BR - Brasile 482
FR - Francia 386
VN - Vietnam 347
GB - Regno Unito 169
UA - Ucraina 168
IN - India 126
FI - Finlandia 115
HK - Hong Kong 114
IE - Irlanda 110
ID - Indonesia 85
JP - Giappone 74
CA - Canada 62
RU - Federazione Russa 54
BD - Bangladesh 48
IQ - Iraq 38
MX - Messico 37
AT - Austria 35
TR - Turchia 33
AR - Argentina 31
ZA - Sudafrica 30
NL - Olanda 28
BE - Belgio 25
KR - Corea 24
ES - Italia 22
AU - Australia 20
IR - Iran 19
PK - Pakistan 18
SA - Arabia Saudita 17
LT - Lituania 16
VE - Venezuela 16
CO - Colombia 14
EG - Egitto 14
CZ - Repubblica Ceca 12
UZ - Uzbekistan 12
CH - Svizzera 10
MA - Marocco 9
CL - Cile 8
KE - Kenya 8
AE - Emirati Arabi Uniti 7
DZ - Algeria 7
JO - Giordania 7
PT - Portogallo 7
RO - Romania 7
KZ - Kazakistan 6
TW - Taiwan 6
CI - Costa d'Avorio 5
CR - Costa Rica 5
MY - Malesia 5
PH - Filippine 5
TN - Tunisia 5
UY - Uruguay 5
AZ - Azerbaigian 4
BG - Bulgaria 4
EU - Europa 4
JM - Giamaica 4
NP - Nepal 4
OM - Oman 4
PY - Paraguay 4
AL - Albania 3
BA - Bosnia-Erzegovina 3
BO - Bolivia 3
DK - Danimarca 3
EC - Ecuador 3
GR - Grecia 3
KH - Cambogia 3
LB - Libano 3
MD - Moldavia 3
NZ - Nuova Zelanda 3
PA - Panama 3
PE - Perù 3
TT - Trinidad e Tobago 3
BB - Barbados 2
ET - Etiopia 2
GE - Georgia 2
MT - Malta 2
NI - Nicaragua 2
NO - Norvegia 2
SN - Senegal 2
VA - Santa Sede (Città del Vaticano) 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AO - Angola 1
BF - Burkina Faso 1
CU - Cuba 1
DM - Dominica 1
EE - Estonia 1
GI - Gibilterra 1
GT - Guatemala 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
IS - Islanda 1
Totale 12.055
Città #
Singapore 896
Ashburn 604
Chandler 488
Warsaw 469
San Jose 379
Fairfield 240
Houston 160
Woodbridge 154
Wilmington 149
Kraków 141
New York 128
Jacksonville 117
Beijing 116
Rome 112
Ho Chi Minh City 111
Dublin 107
Ann Arbor 106
Los Angeles 105
Hong Kong 90
Seattle 90
The Dalles 88
San Mateo 85
Hanoi 84
Hefei 83
Lauterbourg 82
Munich 81
Jakarta 72
Frankfurt am Main 68
Chicago 67
Dallas 65
Milan 64
Nanjing 64
Council Bluffs 63
Cambridge 62
Marseille 62
Tokyo 59
Boston 58
Dearborn 49
Helsinki 45
São Paulo 45
Cattolica 41
Bremen 40
Santa Clara 33
Moscow 31
Nürnberg 31
Boardman 30
London 30
Lawrence 29
Princeton 29
Buffalo 28
Brussels 25
Nuremberg 23
Turku 23
Seoul 22
Kent 21
Nanchang 21
Toronto 20
Redwood City 19
Andover 18
Baghdad 18
Da Nang 18
St Louis 18
Stockholm 18
Vienna 18
Atlanta 17
Brooklyn 17
Lappeenranta 17
Mexico City 17
Paris 17
Trieste 17
Amsterdam 16
Belo Horizonte 16
Chennai 16
Hangzhou 16
Johannesburg 16
Montreal 16
Phoenix 15
Rio de Janeiro 15
Augusta 14
Denver 14
Mumbai 14
North Bergen 14
Washington 14
Shenyang 13
Changsha 12
Dhaka 12
Jiaxing 12
Orem 12
Shanghai 12
Bologna 11
Brno 11
Haiphong 11
Izmir 11
Kunming 11
Poplar 11
San Diego 11
Zhengzhou 11
Campinas 10
Dong Ket 10
Düsseldorf 10
Totale 7.201
Nome #
Increased FGF23 serum level is associated with unstable carotid plaque in type 2 diabetic subjects with internal carotid stenosis. 409
Association between plasma omentin-1 levels in type 2 diabetic patients and peripheral artery disease. 394
The prognostic significance of the Birmingham Vasculitis Activity Score (BVAS) with systemic vasculitis patients transferred to the intensive care unit (ICU) 356
Asthma in patients admitted to emergency department for COVID-19: prevalence and risk of hospitalization 309
Serum high mobility group box-1 and osteoprotegerin levels are associated with peripheral arterial disease and critical limb ischemia in type 2 diabetic subjects. 305
Sortilin levels are associated with peripheral arterial disease in type 2 diabetic subjects 290
The Role of the Microbiota in the Diabetic Peripheral Artery Disease. 288
The Role of the Stem Cells Therapy in the Peripheral Artery Disease. 275
Peroxisome Proliferator-Activated Receptor-alpha is crucial for iloprost-induced in vivo angiogenesis and VEGF upregulation 258
Cilostazol promotes angiogenesis after peripheral ischemia through a VEGF-dependent mechanism 250
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 232
Effects of aging and life-long moderate calorie restriction on IL-15 signaling in the rat white adipose tissue 224
Assessment of the genetic effects of polymorphisms in the osteoprotegerin gene, TNFRSF11B, on serum osteoprotegerin levels and carotid plaque vulnerability. 212
Pioglitazone enhances collateral blood flow in ischemic hindlimb of diabetic mice through an Akt-dependent VEGF-mediated mechanism, regardless of PPARgamma stimulation. 194
Assessment of neurological manifestations in hospitalized patients with COVID-19 194
Sortilin levels correlate with major cardiovascular events of diabetic patients with peripheral artery disease following revascularization: A prospective study 191
Glycaemic variability affects ischaemia-induced angiogenesis in diabetic mice. 187
Gemelli decision tree Algorithm to Predict the need for home monitoring or hospitalization of confirmed and unconfirmed COVID-19 patients (GAP-Covid19): preliminary results from a retrospective cohort study 186
Association between TNFRSF11B gene polymorphisms and history of ischemic stroke in Italian diabetic patients. 186
Cilostazol improves the response to ischemia in diabetic mice by a mechanism dependent on PPARγ. 181
Confirmed or unconfirmed cases of 2019 novel coronavirus pneumonia in Italian patients: a retrospective analysis of clinical features 177
Sortilin/Omentin-1 ratio in Peripheral Artery Disease: a cross-sectional study on 295 unselected elderly patients 176
The role of High-mobility group box protein 1 in collagen antibody-induced arthritis is dependent on Vascular endothelial growth factor. 175
Inflammatory Cytokines Associated With Failure of Lower-Extremity Endovascular Revascularization (LER): A Prospective Study of a Population With Diabetes. 174
Human cord blood endothelial progenitors promote post-ischemic angiogenesis in immunocompetent mouse model. 170
Sonic Hedgehog Regulates Angiogenesis and Myogenesis During Post-Natal Skeletal Muscle Regeneration 166
Association between carotid plaque vulnerability and high mobility group box-1 serum levels in a diabetic population 164
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 163
High-mobility group box-1 protein promotes angiogenesis after peripheral ischemia in diabetic mice through a VEGF-dependent mechanism 163
TNFRSF11B gene polymorphisms increased risk of peripheral arterial occlusive disease and critical limb ischemia in patients with type 2 diabetes 158
Sarilumab use in severe SARS-CoV-2 pneumonia 156
Human cord blood endothelial progenitors promote post-ischemic angiogenesis in immunocompetent mouse model 152
RANK/RANKL/OPG pathway: genetic association with history of ischemic stroke in Italian population 151
Effect of Proinflammatory Gene Polymorphisms on the Risk of Alzheimer's Disease. 148
Association between omentin-1 and major cardiovascular events after lower extremity endovascular revascularization in diabetic patients: A prospective cohort study 139
Pro-Inflammatory Genetic Profiles in Subjects with Peripheral Arterial Occlusive Disease and Critical Limb Ischemia 138
The angiogenic properties of human adipose-derived stem cells (HASCs) are modulated by the High mobility group box protein 1 (HMGB1) 137
New therapeutic effects of cilostazol in patients with ischemic disorders. 135
Impact of COVID-19 pandemic on patients affected by peripheral arterial disease: an Italian single-center study 133
Cilostazol improves the response to ischemia in diabetic mice by a mechanism dependent on PPARγ. 132
Identification of early predictors of clinical outcomes of COVID-19 outbreak in an Italian single center using a machine-learning approach 130
Therapeutic potential of high mobility group box-1 in ischemic injury and tissue regeneration. 129
Neutrophil-to-lymphocyte ratio and clinical outcome in COVID-19: a report from the Italian front line 129
TNFRSF11B gene polymorphisms increased risk of peripheral arterial occlusive disease and critical limb ischemia in patients with type 2 diabetes 124
Statins in High Cardiovascular Risk Patients: Do Comorbidities and Characteristics Matter? 122
Sonic Hedgehog Regulates Angiogenesis and Myogenesis During Post-Natal Skeletal Muscle Regeneration 122
Cardiovascular disease and SARS-CoV-2: The role of host immune response versus direct viral injury 116
High-mobility group box-1 protein promotes angiogenesis after peripheral ischemia in diabetic mice through a VEGF-dependent mechanism 114
Identification of a potential proinflammatory genetic profile influencing carotid plaque vulnerability. 114
Immunosuppressive Therapy (Methotrexate or Cyclophosphamide) in Combination with Corticosteroids in the Treatment of Giant Cell Arteritis: Comparison with Corticosteroids Alone 114
Evaluation of sirtuin 1 as a predictor of cardiovascular outcomes in diabetic patients with limb-threatening ischemia 113
The role of Klotho and FGF23 in cardiovascular outcomes of diabetic patients with chronic limb threatening ischemia: a prospective study 112
Outcomes of Lower Extremity Endovascular Revascularization: Potential Predictors and Prevention Strategies 111
Dietary Risk Factors and Eating Behaviors in Peripheral Arterial Disease (PAD) 108
Internists feel the rhythm 108
Biomarkers of vascular disease in diabetes: the adipose-immune system cross talk 105
Serum high mobility group box-1 levels associated with cardiovascular events after lower extremity revascularization: a prospective study of a diabetic population 104
Development of a biomarker panel for assessing cardiovascular risk in diabetic patients with chronic limb-threatening ischemia (CLTI): a prospective study 104
Endothelial progenitor cells and angiogenesis join the PPARty. 104
Correction to: Association between carotid plaque vulnerability and high mobility group box‑1 serum levels in a diabetic population (Cardiovascular Diabetology, (2021), 20, 1, (114), 10.1186/s12933-021-01304-8) 104
Sex-Based Differences in Clinical Characteristics and Outcomes among Patients with Peripheral Artery Disease: A Retrospective Analysis 103
Peroxisome Proliferator Activeted Receptor and Angiogenesis 103
High mobility group box-1 and diabetes mellitus complications: State of the art and future perspectives 103
Current Medical Therapy and Revascularization in Peripheral Artery Disease of the Lower Limbs: Impacts on Subclinical Chronic Inflammation 100
International Union of angiology consensus document on vascular compression syndromes 97
New therapeutic effects of cilostazol in patients with ischemic disorders 95
Prevalence and characteristics of myocardial injury during COVID-19 pandemic: A new role for high-sensitive troponin 94
Fibroblast growth factor 23 serum level in type 2 diabetic italian subjects with peripheral arterial disease and critical limb ischemia. 93
Identification of a potential proinflammatory genetic profile influencing carotid plaque vulnerability 91
Principal predictors of major adverse limb events in diabetic peripheral artery disease: A narrative review 90
Association of Klotho and FGF23 with cardiovascular outcomes in diabetic older adults with chronic limb-threatening ischemia: a prospective study 86
International Union of angiology Position Statement on no-option chronic limb threatening ischemia 83
Analysis of completion intraoperative venography during first rib resection for venous thoracic outlet syndrome 74
The Role of High-Mobility Group Box-1 and Its Crosstalk with Microbiome in Rheumatoid Arthritis 73
RIvaroxaban and Vascular Surgery (rIVaS): insights from a multicenter, worldwide web-based survey 72
Peroxisome proliferator-activated receptor alpha is crucial for iloprost-induced in vivo angiogenesis and vascular endothelial growth factor upregulation 58
Editorial: Diagnosis, prevention and treatment in diabetic nephropathy 56
International Union of Angiology Position Statement on perioperative drug and hemostasis management in vascular surgery 44
Response to comment on: Biscetti et al. (2010) High-mobility group box-1 protein promotes angiogenesis after peripheral ischemia in diabetic mice through a VEGF-dependent mechanism. Diabetes;59:1496-1505 43
Association of RANK/RANKL/OPG gene polymorphisms with risk of peripheral arterial disease (PAD) and critical limb ischemia in the general Italian population 43
Glycosylation of thrombin activatable fibrinolysis inhibitor: Why is it so important? 38
Residual Traditional Risk in Non-Traditional Atherosclerotic Diseases 24
Prognostic value of lipoprotein(a) for cardiovascular events after lower limb revascularization in diabetic patients with chronic limb-threatening ischemia 22
PCSK9 Predicts Adverse Limb Outcomes After Endovascular Revascularization in Diabetic Chronic Limb-threatening Ischemia 19
Totale 12.219
Categoria #
all - tutte 45.370
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.370


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021134 0 0 0 0 0 0 0 0 0 0 99 35
2021/2022745 59 40 28 45 43 16 26 109 34 66 120 159
2022/20231.417 176 197 121 203 107 151 93 101 146 48 50 24
2023/2024840 33 165 38 52 42 156 87 46 15 40 63 103
2024/20251.796 41 46 134 89 130 71 112 74 222 184 357 336
2025/20264.338 627 172 277 525 801 225 877 252 308 254 20 0
Totale 12.219